Wasatch Advisors Inc Castle Biosciences Inc Transaction History

Wasatch Advisors Inc

$18.5 Billion
Q2 2024

A detailed history of Wasatch Advisors Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 2,327,936 shares of CSTL stock, worth $78.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

2,327,936

Previous 2,551,088 8.75%

Holding current value

$78.6 Million

Previous $56.5 Million 10.31%

% of portfolio

0.27%

Previous 0.3%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.84 - $24.94 $4.2 Million - $5.57 Million	-223,152 Reduced 8.75%	2,327,936 $50.7 Million
Q1 2024 Apr 18, 2024	SELL	$18.06 - $25.3 $719,925 - $1.01 Million	-39,863 Reduced 1.54%	2,551,088 $56.5 Million
Q4 2023 Feb 14, 2024	SELL	$12.19 - $22.43 $2.31 Million - $4.26 Million	-189,793 Reduced 6.83%	2,590,951 $55.9 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $4.07 Million - $6.22 Million	-306,257 Reduced 9.92%	2,780,744 $47 Million
Q2 2023 Aug 07, 2023	BUY	$11.66 - $26.0 $1.25 Million - $2.78 Million	107,088 Added 3.59%	3,087,001 $42.4 Million
Q1 2023 May 12, 2023	SELL	$19.47 - $28.49 $4.72 Million - $6.91 Million	-242,649 Reduced 7.53%	2,979,913 $67.7 Million
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $2.21 Million - $3.67 Million	-122,185 Reduced 3.65%	3,222,562 $75.9 Million
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $8.12 Million - $12.4 Million	-360,771 Reduced 9.74%	3,344,747 $87.2 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $4.19 Million - $12 Million	261,671 Added 7.6%	3,705,518 $81.3 Million
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $10.9 Million - $15.4 Million	327,359 Added 10.5%	3,443,847 $154 Million
Q4 2021 Feb 15, 2022	BUY	$39.06 - $67.58 $24.3 Million - $42.1 Million	622,786 Added 24.97%	3,116,488 $134 Million
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $673,215 - $868,809	-11,196 Reduced 0.45%	2,493,702 $166 Million
Q2 2021 Aug 12, 2021	BUY	$50.07 - $76.78 $7.58 Million - $11.6 Million	151,419 Added 6.43%	2,504,898 $184 Million
Q1 2021 May 10, 2021	BUY	$58.92 - $97.33 $17 Million - $28.1 Million	288,648 Added 13.98%	2,353,479 $161 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $29.9 Million - $50.2 Million	686,774 Added 49.84%	2,064,831 $139 Million
Q3 2020 Nov 10, 2020	BUY	$38.47 - $52.03 $11 Million - $14.9 Million	286,275 Added 26.22%	1,378,057 $70.9 Million
Q2 2020 Aug 12, 2020	BUY	$27.28 - $43.01 $12 Million - $19 Million	441,637 Added 67.93%	1,091,782 $41.1 Million
Q1 2020 May 08, 2020	BUY	$23.08 - $35.53 $6.32 Million - $9.73 Million	273,778 Added 72.74%	650,145 $19.4 Million
Q4 2019 Feb 13, 2020	BUY	$15.74 - $35.04 $1.59 Million - $3.53 Million	100,856 Added 36.61%	376,367 $12.9 Million
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $4.98 Million - $7.69 Million	275,511 New	275,511 $4.98 Million

Others Institutions Holding CSTL

# of Institutions

173

Shares Held

25.5M

Call Options Held

511K

Put Options Held

130K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $888M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account

Wasatch Advisors Inc Castle Biosciences Inc Transaction History